Loading...
Loading...
NOTV| Name | Value |
|---|---|
| Revenues | 130.7M |
| Cost of Revenue | 190.2M |
| Gross Profit | 19.9M |
| Operating Expense | 23.4M |
| Operating I/L | 18.4M |
| Other Income/Expense | -37.2M |
| Interest Income | 0.0M |
| Pretax | -18.8M |
| Income Tax Expense | -1.2M |
| Net Income/Loss | -17.6M |
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries, offering screening, nonclinical safety testing, formulation development, and quality control testing. It also sells analytical instruments to the pharmaceutical development and contract research industries, including in vivo sampling systems, liquid chromatography and electrochemistry instruments, and associated accessories. The company's Contract Research Services segment provides a range of analytical and nonclinical testing services, while its Research Products segment focuses on designing, manufacturing, and marketing in vivo sampling systems and accessories, as well as liquid chromatography and electrochemistry instruments platforms.
